US EditionBB Biotech Takes a Hit in the First Quarter
Summary by finews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
The uncertainties with regard to the US pharmaceutical sector, and the turbulent development in the equity markets as a whole, caused red figures for the investee BB Biotech in the first three months of the year.
The equity company suffered mainly from the continuing uncertainty in the financial markets, geopolitical tensions and the pressure on smaller biotech companies.
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
